The dynamics of HER2 status in esophageal adenocarcinoma.

Oncotarget · 2018 · PMC6003553 · PMID 29928485

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients with pre-treatment HER2-positive tumors showed a trend towards better overall survival, but no association between HER2 discordance and survival was seen.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.